| Date | Company | Amount | Funding type | Investors | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2014-04-07 | Absolute Antibody (UK) | £850K ($1.4M - €1.02 million) | grant | Technology Strategy Board (UK) and business angels | Grant | |
| 2014-04-07 | Genomic Vision (France) | €23 million | IPO | Diagnostic - Cancer - Oncology | IPO | |
| 2014-04-04 | Molmed (Italy) | € 4.969 million | private placement | Fininvest (Italy) Airain Lda (Italy) H-Equity (USA) | Cancer - Oncology | Private placement |
| 2014-04-03 | Genticel (France) | €34.5 million | IPO | Edmond de Rotschild Investment Partners (France), Amundi Private Equity Funds (France), BpiFrance (France), Wellington Partners (USA), IRDI (France) | Infectious diseases - Gynecology - Women's health | IPO |
| 2014-03-28 | Oncodesign (France) | € 12.8 million | IPO | Cancer - Oncology | IPO | |
| 2014-03-28 | Aelis Farma (France) | €1.3 million | seed financing | Inserm Transfert Initiative (France) Aqui Invest (France) Aquitaine Création Investissement (France) | Financing round | |
| 2014-03-25 | Cellectis (France) | €20.5 million | private placement | OrbiMed Advisors (USA), venBio (USA), Ridgeback Capital Management (USA), Aquilo Capital Management (USA), Merlin Nexus (USA) | Cancer - Oncology | Private placement |
| 2014-03-25 | Adaptimmune (UK) | £2.1 million (€2.5 million) | grant | Biomedical Catalyst Fund (UK) | Cancer - Oncology | Grant |
| 2014-03-24 | Transgene (France) | €65.5 million | capital increase | Cancer - Oncology - Infectious diseases | Capital increase | |
| 2014-03-24 | CAP-CMV (Germany) | € 1.7 million | series A financing round | Peppermint Venture Partners (PVP) (Germany), NRW.Bank (Germany), Creathor Venture (Germany), KfW (Germany), private investors | Infectious diseases | Series A financing round |
| 2014-03-20 | Nanobiotix (France) | € 28.1 million | private placement | Cancer - Oncology | Private placement | |
| 2014-03-20 | Saniona (Denmark) | SEK 17 million ($2.64 million - €1.92 million) | IPO | Autoimmune diseases - CNS diseases | IPO | |
| 2014-03-17 | Karo Bio (Sweden) | 1 million SEK (€0.11 million) | grant | Vinnova (Sweden) | Cancer - Oncology | Grant |
| 2014-03-14 | Inotrem (France) | €18 million | series A financing round | Edmond de Rotschild Investment Partners (France) Sofinnova Partners (France) Biomed Invest (Switzerland) Inserm Transfert Initiative (France) | Inflammatory diseases | Series A financing round |
| 2014-03-13 | Circassia (UK) | £200 million (€238 million) | IPO | Allergic diseases - Immunological diseases | IPO | |
| 2014-03-13 | Vectura (UK) | £52.0 million (€62.1 million) | Inflammatory diseases - Respiratory diseases | Private placement | ||
| 2014-03-07 | BiolineRx (Israel) | $24.1 Million (€17.4 million) | public offering of shares | Private placement | ||
| 2014-03-06 | Verona Pharma (UK) | £14.0 million (€16.8 million) | private placement | |||
| 2014-03-04 | Summit (UK) | £22.0 million (€26.7 million) | private placement | Establishment of a new subsidiary in the EU | ||
| 2014-02-28 | Compugen (Israel) | $72.5 million | Private placement |
